AACC Middle East to Showcase Latest in Laboratory Medicine and Diagnostic Innovations

AACC Middle East, a two-day conference held by the American Association for Clinical Chemistry (Washington, DC, USA) in partnership with Life Dx (Abu Dhabi, UAE) will bring the latest in laboratory medicine to the Middle East region and showcase diagnostic innovations. The conference will cover a range of timely topics from infectious disease to big data to prenatal emerging technology as well as core laboratory areas in sample transport, lab management, and quality assurance. Each session will be presented by experts in AACC's scientific leadership to bring the latest in laboratory medicine and build new networks among attendees.

The conference to be held in the Grand Hyatt in Dubai, UAE, from November 5-6 will deliver the latest scientific advances in all disciplines pertinent to the field of laboratory medicine. Leaders in laboratory science and management from countries throughout the region including United Arab Emirates, Kuwait, Oman, Bahrain, Qatar, Saudi Arabia, Jordan, Egypt, Turkey, Lebanon, Cyprus, and the entire African continent have been invited to participate. Attendees will include laboratory directors and managers, government officials, and representatives of the diagnostics industry. AACC Middle East attendees will also have the opportunity to network with their peers and experts from the U.S. and the Middle East to share knowledge on new breakthroughs in laboratory medicine. The conference is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, pathologists, immunologists, fellows, residents, in-training individuals, and other healthcare professionals interested in laboratory medicine.

AACC Middle East attendees will be able to discuss state-of-the-art research and technologies in laboratory medicine, and incorporate laboratory management strategies that enhance workflows and support accurate and effective testing to improve treatment decisions and patient outcomes. They will also be able to implement up-to-date laboratory testing methods, technologies, and data-driven approaches in the preanalytical, analytical, and postanalytical phases of sample handling. Additionally, participants will be able to describe applications and considerations of data analytics and machine learning in clinical laboratories, summarize advances in biomarkers and screening for neurological disease, assessment of kidney function, preeclampsia, and newborn screening, and demonstrate the value and role of laboratory medicine in treatment decisions and patient outcomes.

Related Links:
AACC
Life Dx

Visit expo >

Gold Supplier

HAI Assay Quality Control

Amplichek II

New

Fecal Occult Blood Test

iFOB Assay

New

Albumin Urine Test

Micro-Albumin ELISA

New

D-Dimer Test

Epithod 616 D-Dimer Kit